Evidence map›Paper›PMID 38984872›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2024

Endometriotic Tissue-derived Exosomes Downregulate NKG2D-mediated Cytotoxicity and Promote Apoptosis: Mechanisms for Survival of Ectopic Endometrial Tissue in Endometriosis.

Emma Björk, Pernilla Israelsson, Ivan Nagaev, Olga Nagaeva, Eva Lundin, Ulrika Ottander, Lucia Mincheva-Nilsson

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Enhanced CD56 Expression and Increased Number of CD56American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Endometriosis: An Immunologist's Perspective.International journal of molecular sciences · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emma BjörkDivision of Obstetrics and Gynecology/Örnsköldsvik Hospital, Örnsköldsvik, Sweden.ORCID 0009-0005-6920-5340
Pernilla IsraelssonDepartment of Diagnostics and Intervention/Oncology, Umeå University, Umeå, Sweden.ORCID 0009-0003-8605-8122
Ivan NagaevDepartment of Clinical Microbiology/Infection and Immunology, Umeå University, Umeå, Sweden.
Olga NagaevaDepartment of Clinical Microbiology/Infection and Immunology, Umeå University, Umeå, Sweden.
Eva LundinDepartment of Medical Biosciences/Pathology, Umeå University, Umeå, Sweden.
Ulrika OttanderDepartment of Clinical Sciences/Obstetrics and Gynecology, Umeå University, Umeå, Sweden.ORCID 0000-0002-1383-7753
Lucia Mincheva-NilssonDepartment of Clinical Microbiology/Infection and Immunology, Umeå University, Umeå, Sweden.ORCID 0000-0001-6301-7940

Funding

Cancerfonden (Swedish Cancer Society) CAN 2018/350; no. 18 07 17Central ALFLions Cancer research FoundationRegion Västernorrland LVNFOU992727Västerbotten Läns Landsting (Västerbotten County Council)Vetenskapsrådet (VR) 18-20 - 345240311
6 · The paper itself

Abstract

Endometriosis, affecting 10% of women, is defined as implantation, survival, and growth of endometrium-like/endometriotic tissue outside the uterine cavity, causing inflammation, infertility, pain, and susceptibility to ovarian cancer. Despite extensive studies, its etiology and pathogenesis are poorly understood and largely unknown. The prevailing view is that the immune system of endometriosis patients fails to clear ectopically disseminated endometrium from retrograde menstruation. Exosomes are small extracellular vesicles that exhibit immunomodulatory properties. We studied the role of endometriotic tissue-secreted exosomes in the pathophysiology of endometriosis. Two exosome-mediated mechanisms known to impair the immune response were investigated: 1) downregulation of NKG2D-mediated cytotoxicity and 2) FasL- and TRAIL-induced apoptosis of activated immune cells. We showed that secreted endometriotic exosomes isolated from supernatants of short-term explant cultures carry the NKG2D ligands MICA/B and ULBP1-3 and the proapoptotic molecules FasL and TRAIL on their surface, i.e., signature molecules of exosome-mediated immune suppression. Acting as decoys, these exosomes downregulate the NKG2D receptor, impair NKG2D-mediated cytotoxicity, and induce apoptosis of activated PBMCs and Jurkat cells through the FasL- and TRAIL pathway. The secreted endometriotic exosomes create an immunosuppressive gradient at the ectopic site, forming a "protective shield" around the endometriotic lesions. This gradient guards the endometriotic lesions against clearance by a cytotoxic attack and creates immunologic privilege by induction of apoptosis in activated immune cells. Taken together, our results provide a plausible, exosome-based mechanistic explanation for the immune dysfunction and the compromised immune surveillance in endometriosis and contribute novel insights into the pathogenesis of this enigmatic disease.

Indexed as

ApoptosisEndometriosisEndometriumExosomesNK Cell Lectin-Like Receptor Subfamily KTNF-Related Apoptosis-Inducing LigandAdultCytotoxicity, ImmunologicDown-RegulationFas Ligand ProteinFemaleHistocompatibility Antigens Class IHumansFASLG protein, humanFas Ligand ProteinHistocompatibility Antigens Class IKLRK1 protein, humanNK Cell Lectin-Like Receptor Subfamily KTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, human

Identifiers

PMID38984872
PMCPMC11335327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.